Chanaral Resources Appoints Chairman of Its Advisory Board
October 15, 2007 10:15 ET | Chanaral Resources Inc.
BELLINGHAM, Wash., Oct. 15, 2007 (PRIME NEWSWIRE) -- Chanaral Resources Inc. (Pink Sheets:CRLR) is pleased to announce that the Company has secured the services of Mr. Carl O. Windels in the position...
Gulf Western Petroleum Announces Flow Test Results on Shamrock Project Polinard-Lee Frio Well
October 15, 2007 08:49 ET | Gulf Western Petroleum Corporation
HOUSTON, Oct. 15, 2007 (PRIME NEWSWIRE) -- Gulf Western Petroleum Corporation ("Gulf Western") (OTCBB:GWPC) (Frankfurt:GER) is pleased to announce flow test results of the Polinard-Lee No. 1 gas unit...
Basilea-Logo.jpg
Schweizer Gesundheitsbehörde akzeptiert das Zulassungsgesuch für Alitretinoin zur weiteren Beurteilung
October 15, 2007 01:15 ET | Basilea Pharmaceutica AG
Basel, 15 Oktober, 2007 - Basilea Pharmaceutica AG (SWX:BSLN) gab heute bekannt, dass Swissmedic das Zulassungsgesuch für Alitretinoin zur oralen Behandlung des schweren therapierefraktären...
Basilea-Logo.jpg
Swiss Regulatory Authority Accepts for Review the Marketing Authorization Application for Alitretinoin
October 15, 2007 01:15 ET | Basilea Pharmaceutica AG
Basel, Switzerland, October 15, 2007 - Basilea Pharmaceutica Ltd. (SWX:BSLN) announced today that Swissmedic has accepted for review, the marketing authorization application for alitretinoin. This...
Basilea-Logo.jpg
Marketing Authorization Application for Alitretinoin Accepted by European Health Authorities
October 11, 2007 01:15 ET | Basilea Pharmaceutica AG
Basel, Switzerland, October 11, 2007 - Basilea Pharmaceutica Ltd. (SWX:BSLN) announced today that the Marketing Authorization Application (MAA) for alitretinoin submitted to various EU Member States...
Basilea-Logo.jpg
Europäische Gesundheitsbehörden akzeptieren Zulassungsantrag für Alitretinoin
October 11, 2007 01:15 ET | Basilea Pharmaceutica AG
Basel, 11. Oktober, 2007 - Basilea Pharmaceutica AG (SWX:BSLN) gab heute bekannt, dass der EU-Zulassungsantrag für Alitretinoin von den zuständigen nationalen Gesundheitsbehörden zur Bewertung...
Epigenomics AG Forms Medical Advisory Board For Colorectal Cancer Screening
October 10, 2007 03:12 ET | Epigenomics AG
BERLIN and SEATTLE, Oct. 10, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (ISIN:DE000A0BVT96) today announced the formation of its Colorectal Cancer Medical Advisory board and the...
Zecotek Photonics Inc. Logo
Zecotek Completes Installation of First Vanadate Crystal Growing Oven; Initial Orders Currently in Production
October 09, 2007 09:00 ET | Zecotek Photonics Inc.
VANCOUVER, British Columbia, Oct. 9, 2007 (PRIME NEWSWIRE) -- Zecotek Medical Systems Inc. (TSX-V:ZMS) (Frankfurt: W1I) today announced it has installed the first in a planned series of four vanadate...
Jerini Ophthalmic Treats First Patient in Phase I Trial for Age-related Macular Degeneration
October 09, 2007 03:11 ET | Jerini AG
BERLIN, Oct. 9, 2007 (PRIME NEWSWIRE) -- Jerini AG (Frankfurt:JI4) announced today that its wholly-owned subsidiary, Jerini Ophthalmic, Inc., has treated the first patient in its Phase I clinical...
Basilea-Logo.jpg
Basilea gibt erste positive Resultate der Phase-III-Studie zu Ceftobiprol bei im Krankenhaus erworbener Lungenentzündung bekannt
October 09, 2007 01:15 ET | Basilea Pharmaceutica AG
Basel, 9. Oktober, 2007  -  Basilea Pharmaceutica AG gab heute bekannt, dass die Phase-III-Studie zu Ceftobiprol in der Behandlung von im Krankenhaus erworbener Lungenentzündung den primären...